40164_2019_138_MOESM1_ESM.docx (30.3 kB)
MOESM1 of Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
journal contribution
posted on 2019-07-03, 05:00 authored by Ravi Potluri, Sandip Ranjan, Hitesh Bhandari, Helen Johnson, Andriy Moshyk, Srividya KotapatiAdditional file 1. Basis for inclusion of drug and non-drug resources in the cost comparison analysis.